These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33662349)

  • 1. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
    Morales-García LJ; Pacheco-Delgado MS
    Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study.
    Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N
    Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Free Light Chain Reference Intervals in a Local Population in Spain using the Optilite Analyser.
    Rocamonde L; Hermida FJ
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population.
    Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH
    Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications.
    Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS
    Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
    Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
    Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
    Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
    Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 2 Serum Free Light Chain Assays with Creatinine Normal and Abnormal Populations Demonstrates the Need for Standardization.
    Griffiths M; Cheng PL; Wang XY; Schneider R; Kulasingam V
    J Appl Lab Med; 2024 Sep; 9(5):978-988. PubMed ID: 38973026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
    Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
    Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
    J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
    Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
    Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
    Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An updated diagnostic range for serum free light chain kappa/lambda ratio using Freelite reagents on BN II or Optilite.
    Li B; King R; Chan B; Rollo C; Thompson S; Florkowski C
    Pathology; 2024 Aug; 56(5):732-734. PubMed ID: 38705800
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment of reference intervals for free light chains and immunoglobulins in Saudi population.
    Borai A; Ichihara K; Tamimi W; Masaud A; Sobki S
    Clin Chem Lab Med; 2024 Feb; 62(3):522-529. PubMed ID: 37787915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer.
    Augustijn D; Jacobs JFM; Russcher H
    Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform.
    Muluhngwi P; Sharp CN; Pozzi N; Elin RJ; Jortani SA
    J Appl Lab Med; 2019 Nov; 4(3):323-330. PubMed ID: 31659070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.